CASTRES, France, June 28, 2010 /PRNewswire/ -- Mr Jean-Pierre Garnier will step down onSeptember 1st 2010, two years after having been appointed CEO of the Pierre Fabre Group.
"The Company is in excellent health, and is poised to experience a bright future ; I am glad to have contributed to its
Mr. Pierre Fabre thanked Mr Jean-Pierre Garnier for his "commitment and the excellent work performed" and stated that "his contribution over the past two years has been of the utmost benefit to the Company".
The new governance, which will continue in the spirit of the current organisation, will be announced in the near future.
About Pierre Fabre group : The Pierre Fabre Group, the second largest independent French pharmaceutical company and leader in the field of in-pharmacy dermocosmetics, employs about 10,000 people worldwide, including 1,400 R&D staff, and generates a turnover of EUR 1.8 billion. In 2009, Pierre Fabre Medicament dedicated 28% of its annual turnover to R&D in four priority therapeutic areas in public health: oncology, central nervous system, dermatology, cardio-vascular/metabolism. To learn more about Pierre Fabre, please refer to http://www.pierre-fabre.com. Press Contact : Djamila Hazene-Kedjem firstname.lastname@example.org +33(0)1-49-10-81-72 / +33(6)89-45-87-95
SOURCE Groupe Pierre Fabre
Subscribe to our Free Newsletters!
Discover the amazing health benefits of this ''under-valued'' vegetable called leek. Know the ...
Dehydration occurs when there is depletion of body fluids without adequate replacement. Test your ...
Cardiopulmonary bypass is a technique which allows performing open heart surgical procedures in a ...View All